Document ID: chunk:federal_register_of_legislation:F2025L00217:schedule:1
Version: federal_register_of_legislation:F2025L00217
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2466–5445

Schedule 1—Amendments

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)
     1.            Schedule 1, entries for Amoxicillin with clavulanic acid
    omit:
Amoxicillin with clavulanic acid  Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 100 mL (S19A)

     1.            Schedule 1, entries for Azithromycin
    omit:
Azithromycin  Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL (S19A)

     1.            Schedule 4, entries for Amoxicillin with clavulanic acid
    omit:
Amoxicillin with clavulanic acid  Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 100 mL (S19A)

     1.            Schedule 4, entries for Azithromycin
    omit:
Azithromycin  Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL (S19A)

     1.            Schedule 4, entries for Budesonide with formoterol
    omit:
Budesonide with formoterol  Pressurised inhalation containing budesonide 50 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses

     1.            Schedule 4, after entry for Esomeprazole and clarithromycin and amoxicillin in the form Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)
    insert:
Estradiol  Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses

     1.            Schedule 4, after entry for Estradiol in the form Transdermal patches 1.56 mg, 8
    insert:
Estradiol  Transdermal patches 1.56 mg, 24 (Sandoz) (S19A)

     1.            Schedule 4, after entry for Estradiol with norethisterone in the form Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8
    insert:
Estradiol with norethisterone  Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 (S19A)

     1.            Schedule 4, after entry for Estradiol with norethisterone in the form Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8
    insert:
Estradiol with norethisterone  Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 (S19A)

     1.        Schedule 4, after entry for Prednisolone with phenylephrine
    insert:
Progesterone and estradiol  Pack containing 30 capsules progesterone 100 mg (micronised) and transdermal gel (pump pack) estradiol 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses

     1.        Schedule 4, entries for Timolol
    omit:
Timolol  Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL (S19A)